A 40-year analysis of 265 gastric carcinoids

American Journal of Gastroenterology

Volumn 92, Issue 4, 1997, Pages 633-638

  Modlin, Irvin M ^a   Sandor, Andras ^b   Tang, Laura H ^b   Kidd, Mark ^b   Zelterman, Daniel ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOID; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH TUMOR; SURVIVAL RATE; TUMOR LOCALIZATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; CARCINOID TUMOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; SEX DISTRIBUTION; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 0030891863     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Solcia E, Fiocca R, Villani R, et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol 1991;26(suppl 180): 146-59.
2. Waldum HL, Haugen OA, Isaksen C, et al. Enterochromaffin-like tumour cells in the diffuse but not the intestinal type of gastric carcinomas. Scand J Gastroenterol 1991;26(suppl 180):165-9.
3. Capella C, Polak JM, Timson CM, et al. Gastric carcinoids of argyrophil ECL cells. Ultrastruct Pathol 1980;1:411-8.
4. Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study. Gastroenterology 1993;104:994-1006.
5. Brittain RJD, Reeves JJ, Stables R. Pharmacological basis for the induction of gastric carcinoid tumors in the rat by loxtidine, an insurmountable histamine H2-receptor blocking drug. Br J Pharmacol 1985; 85:843-7.
6. Bilchik AJ, Nilsson O, Modlin IM, et al. H2-receptor blockade induces peptide YY (PYY) and enteroglucagon (EG) secreting gastric carcinoids in mastomys. Surgery 1989;106:1119-27.
7. Solcia E, Rindi G, Silini E, et al. Enterochromaffin-like (ECL) cells and their growth: Relationships to gastrin, reduced acid secretion and gastritis. Baillieres Clin Gastroenterol 1993;7:149-65.
8. Ahlman H, Kolby L, Lundell L, et al. Clinical management of gastric carcinoid tumors. Digestion 1994;55(suppl 3):77-85.
9. Modlin IM, Gilligan CJ, Lawton GP, et al. Gastric carcinoids: The Yale experience. Arch Surg 1995;130:250-6.
10. Thomas RM, Baybick JH, Elsayed AM, et al. Gastric carcinoids. An immunohistochemical and clinicopathological study of 104 patients. Cancer 1994;73:2053-8.
11. Godwin JD. Carcinoid tumors. An analysis of 2837 cases. Cancer 1975;36:560-9.
12. SEER Cancer Statistics Review, Bethesda, MD: US Department of Health and Human Services, Public Health Institute, National Institutes of Health, National Cancer Institute, 1993.
13. Percy C, Young JL, Muir C, et al. Introduction to histology of cancer, incidence and prognosis: Seer population-based data, 1973-1987. Cancer 1995;75:140-6.
14. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer 1995;75:154-70.
15. Histology of cancer incidence and prognosis: SEER Population-based data 1973-1987. Cancer 1995;75(suppl)1:1-421.
16. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol 1995;32:545-61.
17. Cadiot G, Lehy T, Mignon M. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome. Acta Oncol 1993;32:135-40.
18. Staren ED, Lott S, Saavedra VM, et al. Neuroendocrine carcinomas of the stomach: A clinicopathologic evaluation. Surgery 1992;112:1039-47.
19. Modlin IM, Zucker K, Zdon M, et al. Characteristics of the spontaneous gastric endocrine tumor of mastomys. J Surg Res 1988;44:205-15.
20. Wormsley KG. Is hypergastrinemia dangerous for man? Scand J Gastroenterol 1991;26(suppl 180):174-8.
21. Creutzfeldt W, Lamberts R. Is hypergastrinemia dangerous to man? Scand J Gastroenterol 1991;26(suppl 180):179-91.
22. McCloy RF, Arnold R, Bardhan KD, et al. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci 1995;40:96S-120S.
23. Cadiot G, Laurent-Puig P, Thuille B, et al. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 1993;105:579-82.